and other data for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Critics say regulation is needed but a voluntary approach may be more effective
Some fear progress on NTDs will stall if priorities shift in new era
Aid scores success in Latin America; Africa battles on
Drug companies have shown a willingness to share, even when the rewards are low